• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

地尔硫䓬从乙基化β-环糊精复合物中的缓释特性。

Slow-release characteristics of diltiazem from ethylated beta-cyclodextrin complexes.

作者信息

Horiuchi Y, Hirayama F, Uekama K

机构信息

Faculty of Pharmaceutical Sciences, Kumamoto University, Japan.

出版信息

J Pharm Sci. 1990 Feb;79(2):128-32. doi: 10.1002/jps.2600790211.

DOI:10.1002/jps.2600790211
PMID:2324960
Abstract

Release characteristics of two ethylated beta-cyclodextrins [heptakis(2,6-di-O-ethyl)-beta-cyclodextrin (diethyl-beta-cyclodextrin) and heptakis(2,3,6-tri-O-ethyl)-beta-cyclodextrin (triethyl-beta-cyclodextrin)] as sustained-release drug carriers were evaluated using diltiazem hydrochloride, a water-soluble calcium antagonist. The release rate of diltiazem from compressed tablets was significantly retarded by the complexation with ethylated beta-cyclodextrin. Various environmental effects (such as pH, rotating speed, and additive in the dissolution medium) on the release rate were investigated, together with a microscopic observation of the tablet surface. The water penetration rate into the tablet was measured in order to gain insight into the release mechanism. The results suggested that diltiazem is released slowly from the hydrophobic matrix consisting of diethyl-beta-cyclodextrin following water penetration. When a single dose of tablets containing diethyl-beta-cyclodextrin complex was orally administered to dogs, the sustained-release pattern of the drug, without decrease in area under the plasma concentration-time curve, was produced for a long period. The release rate of diltiazem can be controlled by combining the ethylated beta-cyclodextrin complexes with the parent beta-cyclodextrin complex in different mixing ratios.

摘要

以水溶性钙拮抗剂盐酸地尔硫䓬为模型药物,评估了两种乙基化β-环糊精[七(2,6-二-O-乙基)-β-环糊精(二乙基-β-环糊精)和七(2,3,6-三-O-乙基)-β-环糊精(三乙基-β-环糊精)]作为缓释药物载体的释放特性。与乙基化β-环糊精络合后,盐酸地尔硫䓬从压制片中的释放速率显著减慢。研究了各种环境因素(如pH值、转速和溶出介质中的添加剂)对释放速率的影响,并对片剂表面进行了显微镜观察。测量了水进入片剂的渗透率,以深入了解释放机制。结果表明,水渗透后,地尔硫䓬从由二乙基-β-环糊精组成的疏水基质中缓慢释放。当给犬口服单剂量含二乙基-β-环糊精络合物的片剂时,药物的缓释模式得以维持,血浆浓度-时间曲线下面积无下降。通过将乙基化β-环糊精络合物与母体β-环糊精络合物以不同混合比例混合,可以控制地尔硫䓬的释放速率。

相似文献

1
Slow-release characteristics of diltiazem from ethylated beta-cyclodextrin complexes.地尔硫䓬从乙基化β-环糊精复合物中的缓释特性。
J Pharm Sci. 1990 Feb;79(2):128-32. doi: 10.1002/jps.2600790211.
2
O-carboxymethyl-O-ethylcyclomaltoheptaose as a delayed-release-type drug carrier: improvement of the oral bioavailability of diltiazem in the dog.O-羧甲基-O-乙基环麦芽七糖作为一种缓释型药物载体:改善犬体内地尔硫䓬的口服生物利用度
Carbohydr Res. 1989 Oct 23;192:323-30. doi: 10.1016/0008-6215(89)85190-0.
3
Utilization of diethyl-beta-cyclodextrin as a sustained-release carrier for isosorbide dinitrate.利用二乙基-β-环糊精作为硝酸异山梨酯的缓释载体。
J Pharm Sci. 1988 Mar;77(3):233-6. doi: 10.1002/jps.2600770310.
4
Ethylated beta-cyclodextrins as hydrophobic drug carriers: sustained release of diltiazem in the rat.乙基化β-环糊精作为疏水性药物载体:大鼠体内地尔硫卓的缓释
J Pharm Sci. 1987 Aug;76(8):660-1. doi: 10.1002/jps.2600760816.
5
[Development and pharmaceutical evaluation of hydrophobic cyclodextrin derivatives as modified-release drug carriers].[疏水性环糊精衍生物作为缓释药物载体的研发与药学评价]
Yakugaku Zasshi. 1993 Jun;113(6):425-37. doi: 10.1248/yakushi1947.113.6_425.
6
Inclusion complexation of heptakis(2,6-di-O-ethyl)-beta-cyclodextrin with tiaprofenic acid: pharmacokinetic consequences of a pH-dependent release and stereoselective dissolution.七(2,6-二-O-乙基)-β-环糊精与噻洛芬酸的包合络合作用:pH依赖性释放和立体选择性溶解的药代动力学后果
J Pharm Sci. 1995 Aug;84(8):1014-9. doi: 10.1002/jps.2600840819.
7
Sustained release of buserelin acetate, a luteinizing hormone-releasing hormone agonist, from an injectable oily preparation utilizing ethylated beta-cyclodextrin.利用乙基化β-环糊精从注射用油剂中持续释放醋酸布舍瑞林(一种促黄体生成素释放激素激动剂)。
J Pharm Pharmacol. 1989 Dec;41(12):874-6. doi: 10.1111/j.2042-7158.1989.tb06393.x.
8
Effect of diethyl-beta-cyclodextrin on the release of nitroglycerin from formulations.二乙基-β-环糊精对制剂中硝酸甘油释放的影响。
Drug Des Deliv. 1990 Oct;6(4):297-310.
9
Hydrophilic and hydrophobic cyclodextrins in a new sustained release oral formulation of nicardipine: in vitro evaluation and bioavailability studies in rabbits.尼卡地平新型缓释口服制剂中亲水性和疏水性环糊精:家兔体内的体外评价和生物利用度研究
J Control Release. 2003 Feb 14;88(1):127-34. doi: 10.1016/s0168-3659(02)00465-0.
10
In-vivo and in-vitro evaluations of a modified-release oral dosage form of nifedipine by hybridization of hydroxypropyl-beta-cyclodextrin and hydroxypropylcelluloses in dogs.
J Pharm Pharmacol. 1994 Jun;46(6):505-7. doi: 10.1111/j.2042-7158.1994.tb03836.x.

引用本文的文献

1
Preparation and in vitro Evaluation of Ethylcellulose Coated Egg Albumin Microspheres of Diltiazem Hydrochloride.盐酸地尔硫䓬乙基纤维素包衣白蛋白微球的制备及体外评价
J Young Pharm. 2010 Jan;2(1):27-34. doi: 10.4103/0975-1483.62209.
2
Thermosensitive Pluronic hydrogel: prolonged injectable formulation for drug abuse.热敏性普朗尼克水凝胶:用于药物滥用的长效可注射制剂。
Drug Des Devel Ther. 2010 Sep 24;4:255-62. doi: 10.2147/dddt.s13289.
3
Cyclodextrins in drug delivery: an updated review.环糊精在药物递送中的应用:最新综述
AAPS PharmSciTech. 2005 Oct 14;6(2):E329-57. doi: 10.1208/pt060243.
4
Preparation of heptakis(2,6-di-O-ethyl)-beta-cyclodextrin and its nuclear magnetic resonance spectroscopic characterization.
Pharm Res. 1993 Feb;10(2):208-13. doi: 10.1023/a:1018926508695.